SCHEMBL175366

SCHEMBL175366

CC(=O)OCCCc1ccc(C(=O)c2sc(N)nc2-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
HSD17B10 Q99714 1/20 0.53
ADORA3 P0DMS8 7/20 0.45
LMNA P02545 4/20 0.45
NPSR1 Q6W5P4 4/20 0.45
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ADORA2B P29275 2/20 0.45
CYP1A2 P05177 1/20 0.44
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
ADORA1 P30542 3/20 0.43
GAA P10253 1/20 0.43
CFTR P13569 1/20 0.42
ADORA2A P29274 1/20 0.41
RORB Q92753 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL176165 0.94 ALDH1A1 (0.55) ALDH1A1HSD17B10ADORA3LMNANPSR1
SCHEMBL4267596 0.86 ALDH1A1 (0.55) ALDH1A1HSD17B10ADORA3LMNANPSR1
SCHEMBL175591 0.82 RORC (0.47) ALDH1A1HSD17B10ADORA3ADORA1ADORA2A
SCHEMBL175193 0.81 ALDH1A1 (0.52) ALDH1A1HSD17B10ADORA3LMNANPSR1
SCHEMBL165773 0.78 ADORA3 (0.61) ALDH1A1HSD17B10ADORA3LMNANPSR1
SCHEMBL175315 0.76 RORC (0.77) RORB
SCHEMBL257616 0.75 ADORA3 (0.64) ALDH1A1HSD17B10ADORA3LMNANPSR1
SCHEMBL27653923 0.74 ALDH1A1 (0.64) ALDH1A1HSD17B10ADORA3NPSR1HTT
SCHEMBL330400 0.71 ALDH1A1 (0.65) ALDH1A1HSD17B10LMNANPSR1SMN1; SMN2
SCHEMBL1051 0.71 LMNA (0.68) ALDH1A1LMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027965-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-08 WO disclosed
WO-2012027965-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-08 WO disclosed